Abuse of patent rights for pharmaceuticals in wartime conditions

The article addresses the issue of patent rights abuse in relation to pharmaceuticals during wartime conditions. The aim of the study is to summarize the problems of patent rights abuse in the national legislation, identify ways to resolve them, and formulate conclusions to reduce such abuses. The s...

Full description

Saved in:
Bibliographic Details
Main Authors: A.O. Kodynets, O.F. Doroshenko, I.P. Volynets, G.K. Dorozhko, V.O. Petrenko, V.V. Belitsky
Format: Article
Language:English
Published: Dnipro State Medical University 2024-12-01
Series:Medičnì Perspektivi
Subjects:
Online Access:https://journals.uran.ua/index.php/2307-0404/article/view/319395
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841537379359260672
author A.O. Kodynets
O.F. Doroshenko
I.P. Volynets
G.K. Dorozhko
V.O. Petrenko
V.V. Belitsky
author_facet A.O. Kodynets
O.F. Doroshenko
I.P. Volynets
G.K. Dorozhko
V.O. Petrenko
V.V. Belitsky
author_sort A.O. Kodynets
collection DOAJ
description The article addresses the issue of patent rights abuse in relation to pharmaceuticals during wartime conditions. The aim of the study is to summarize the problems of patent rights abuse in the national legislation, identify ways to resolve them, and formulate conclusions to reduce such abuses. The study employs general scientific and specialized methods of scientific cognition, including dialectical, formal-logical, system-structural, comparative-legal methods, as well as modeling, analysis, and synthesis. Together, these methods facilitated the organization, planning, and execution of the research. The information search covered the period from 2001 to 2024. The study is based on scientific publications from databases and search engines (PubMed, JAMA, Scopus, Springer, BMC, Oxford Academic, Cairn.info), international and domestic legal acts, statistical studies of international organizations (Precedence Research, Statista, Proxima Research), patents on inventions related to pharmaceuticals, court rulings, and the recommendations of international and domestic experts. The inclusion criteria for materials were scientific articles, legal acts, court rulings, and analytical reviews related to pharmaceutical patent rights, patent monopoly abuses, "evergreening" patents, and unfair competition in the pharmaceutical industry. The following search queries were used: "abuse of patent rights on pharmaceuticals," "patent monopoly in the pharmaceutical industry," "evergreening patents," "unfair competition in the pharmaceutical market," and "intellectual property in wartime conditions." Exclusion criteria included sources unrelated to the legal regulation of pharmaceutical patents, materials not directly connected with patent rights, and publications that did not meet scientific standards and credibility. It has been determined that patent monopolies can lead to higher drug prices, the prevention of generic drug production, import dependency, reduced competitiveness, and other consequences. Additionally, the creation of "evergreening" patents affects competitive relations, representing a form of unfair competition. Examples of patent monopolies in pharmaceuticals owned by major global pharmaceutical companies (Gilead, Merck Sharp & Dohme Corp., etc.) were examined. Attention is drawn to the problematic aspects of legislative implementation to strengthen the protection of individuals’ interests in the field of intellectual property during martial law, which leads to misinterpretation and implementation of relevant provisions and requires updating. Court cases of pharmaceutical companies regarding the artificial maintenance of patent monopolies and the blocking of generic drugs entering the Ukrainian market were analyzed. The need for updating and improving the legislative mechanism for regulating the validity of invention patents has been emphasized.
format Article
id doaj-art-31f970ed6f4b49888a936e452dfb5af6
institution Kabale University
issn 2307-0404
2786-4804
language English
publishDate 2024-12-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-31f970ed6f4b49888a936e452dfb5af62025-01-14T08:36:59ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042786-48042024-12-0129423724610.26641/2307-0404.2024.4.319395358034Abuse of patent rights for pharmaceuticals in wartime conditionsA.O. Kodynets0https://orcid.org/0000-0002-0954-1474O.F. Doroshenko1https://orcid.org/0000-0002-2542-2328I.P. Volynets2https://orcid.org/0000-0002-2029-2165G.K. Dorozhko3https://orcid.org/0000-0001-6506-3203V.O. Petrenko4https://orcid.org/0000-0001-5017-1674V.V. Belitsky5https://orcid.org/0000-0002-2841-7372Taras Shevchenko National University of Kyiv, Volodymyrska str., 60; Intellectual Property Scientific Research Institute of National Academy of Legal Sciences of Ukraine, K. Malevycha str., 11, Kyiv, 03150Intellectual Property Scientific Research Institute of National Academy of Legal Sciences of Ukraine, K. Malevycha str., 11, Kyiv, 03150Intellectual Property Scientific Research Institute of National Academy of Legal Sciences of Ukraine, K. Malevycha str., 11, Kyiv, 03150Intellectual Property Scientific Research Institute of National Academy of Legal Sciences of Ukraine, K. Malevycha str., 11, Kyiv, 03150Ukrainian State University of Science and Technologies, Institute of Industrial and Business Technologies, Haharin av., 4, Dnipro, 49005Dnipro State Medical University, Volodymyra Vernadskoho str., 9, Dnipro, 49044The article addresses the issue of patent rights abuse in relation to pharmaceuticals during wartime conditions. The aim of the study is to summarize the problems of patent rights abuse in the national legislation, identify ways to resolve them, and formulate conclusions to reduce such abuses. The study employs general scientific and specialized methods of scientific cognition, including dialectical, formal-logical, system-structural, comparative-legal methods, as well as modeling, analysis, and synthesis. Together, these methods facilitated the organization, planning, and execution of the research. The information search covered the period from 2001 to 2024. The study is based on scientific publications from databases and search engines (PubMed, JAMA, Scopus, Springer, BMC, Oxford Academic, Cairn.info), international and domestic legal acts, statistical studies of international organizations (Precedence Research, Statista, Proxima Research), patents on inventions related to pharmaceuticals, court rulings, and the recommendations of international and domestic experts. The inclusion criteria for materials were scientific articles, legal acts, court rulings, and analytical reviews related to pharmaceutical patent rights, patent monopoly abuses, "evergreening" patents, and unfair competition in the pharmaceutical industry. The following search queries were used: "abuse of patent rights on pharmaceuticals," "patent monopoly in the pharmaceutical industry," "evergreening patents," "unfair competition in the pharmaceutical market," and "intellectual property in wartime conditions." Exclusion criteria included sources unrelated to the legal regulation of pharmaceutical patents, materials not directly connected with patent rights, and publications that did not meet scientific standards and credibility. It has been determined that patent monopolies can lead to higher drug prices, the prevention of generic drug production, import dependency, reduced competitiveness, and other consequences. Additionally, the creation of "evergreening" patents affects competitive relations, representing a form of unfair competition. Examples of patent monopolies in pharmaceuticals owned by major global pharmaceutical companies (Gilead, Merck Sharp & Dohme Corp., etc.) were examined. Attention is drawn to the problematic aspects of legislative implementation to strengthen the protection of individuals’ interests in the field of intellectual property during martial law, which leads to misinterpretation and implementation of relevant provisions and requires updating. Court cases of pharmaceutical companies regarding the artificial maintenance of patent monopolies and the blocking of generic drugs entering the Ukrainian market were analyzed. The need for updating and improving the legislative mechanism for regulating the validity of invention patents has been emphasized.https://journals.uran.ua/index.php/2307-0404/article/view/319395patent monopoly“evergreen” patentsmedicinesunfair competitionintellectual propertywartime conditions
spellingShingle A.O. Kodynets
O.F. Doroshenko
I.P. Volynets
G.K. Dorozhko
V.O. Petrenko
V.V. Belitsky
Abuse of patent rights for pharmaceuticals in wartime conditions
Medičnì Perspektivi
patent monopoly
“evergreen” patents
medicines
unfair competition
intellectual property
wartime conditions
title Abuse of patent rights for pharmaceuticals in wartime conditions
title_full Abuse of patent rights for pharmaceuticals in wartime conditions
title_fullStr Abuse of patent rights for pharmaceuticals in wartime conditions
title_full_unstemmed Abuse of patent rights for pharmaceuticals in wartime conditions
title_short Abuse of patent rights for pharmaceuticals in wartime conditions
title_sort abuse of patent rights for pharmaceuticals in wartime conditions
topic patent monopoly
“evergreen” patents
medicines
unfair competition
intellectual property
wartime conditions
url https://journals.uran.ua/index.php/2307-0404/article/view/319395
work_keys_str_mv AT aokodynets abuseofpatentrightsforpharmaceuticalsinwartimeconditions
AT ofdoroshenko abuseofpatentrightsforpharmaceuticalsinwartimeconditions
AT ipvolynets abuseofpatentrightsforpharmaceuticalsinwartimeconditions
AT gkdorozhko abuseofpatentrightsforpharmaceuticalsinwartimeconditions
AT vopetrenko abuseofpatentrightsforpharmaceuticalsinwartimeconditions
AT vvbelitsky abuseofpatentrightsforpharmaceuticalsinwartimeconditions